Literature DB >> 32855152

Colchicine treatment in community healthcare setting to prevent severe COVID-19.

Emanuel Della-Torre1,2, Giuseppe A Ramirez3,2, Lorenzo Dagna3,2, Moreno Tresoldi4.   

Abstract

Entities:  

Keywords:  anti-inflammatory agents; health care; inflammation; non-steroidal; outcome assessment

Mesh：

Substances：

Year:  2020        PMID： 32855152     DOI： 10.1136/annrheumdis-2020-218759

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  2 in total

1.  Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.

Authors:  Emanuel Della-Torre; Marco Lanzillotta; Corrado Campochiaro; Giulio Cavalli; Giacomo De Luca; Alessandro Tomelleri; Nicola Boffini; Rebecca De Lorenzo; Annalisa Ruggeri; Patrizia Rovere-Querini; Antonella Castagna; Giovanni Landoni; Moreno Tresoldi; Fabio Ciceri; Alberto Zangrillo; Lorenzo Dagna
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

2.  Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.

Authors:  Luigi Brunetti; Oumou Diawara; Andrew Tsai; Bonnie L Firestein; Ronald G Nahass; George Poiani; Naomi Schlesinger
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.